Bioinformatics visualisation specialist Qlucore has released the beta version of its Qlucore Omics Explorer 3.3 software, including a completely new Next Generation Sequencing (NGS) Module and range of new functionalities for the base version. The NGS Module will enable additional functionality related to data generated with NGS technologies, making it possible to interactively and dynamically visualise, analyse and explore NGS data.
Qlucore Omics Explorer is a next-generation bioinformatics software program for broad usage known for its friendly user interface and advanced visualisation capabilities that enables biologists and researchers who are not data analysis experts to explore NGS and data, find new answers and generate new hypotheses.
Examples include RNA-seq studies, is one of the most used techniques in modern genetics and cancer research, with the NGS Module enabling a comprehensive and synchronised view of both expression levels and genomic locations. A unique flexibility is handed to the user, who can perform a statistical test in the expression space by simply moving a cut-off slider, observing the result in the Genome browser, one of the main components in the NGS Module which, in combination with the dynamic filters, ensures that the user always visualises the most interesting regions of the genome, minimising the need for zoom and scroll.
For further information on Qlucore and its new software visit www.qlucore.com
Latest from Tom Mulligan
- EVENT PREVIEW: CPhI North America opens next week!
- NEW BUSINESS: SK biotek and AMPAC Fine Chemicals have ambitious CDMO plans
- NEW TECHNOLOGY: Polyplus-transfection develops GMP-grade therapeutic virus reagent
- Mogrify raises $3.7 million seed funding to support direct cellular conversion for cell therapy
- Owlstone Medical partners with Shanghai Renji Hospital to pioneer Breath Biopsy lung cancer trial
- Chemspace and LabNetwork collaborate to extend access to chemical databases
- TECHNOLOGY UPDATE: Catalent invests over $27 million to commercialise next-generation ODT Zydis Ultra
- SGS reports successful Phase 2 results for novel influenza vaccine, validating its H3N2 A/Belgium challenge agent
- NEW TECHNOLOGY: Horizon Discovery and Rutgers University develop new gene editing approach: ‘base editing’
- EVENT REVIEW: Busy sessions at BIO-Europe Spring!